中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Development of an FAP-Targeted PET Probe Based on a Novel Quinolinium Molecular Scaffold

文献类型:期刊论文

作者Li, Lei6,7,8; Cao, Rui5; Chen, Kaixin6,7,8; Qu, Chunrong6,7; Qian, Kun6,7; Lin, Jia6,7,8; Li, Renda4; Lai, Chaoquan4; Wang, Xiao3; Han, Zijian2
刊名BIOCONJUGATE CHEMISTRY
出版日期2024-07-02
页码9
ISSN号1043-1802
DOI10.1021/acs.bioconjchem.4c00214
通讯作者Song, Shaoli(shaoli-song@163.com) ; Zhu, Weiliang(wlzhu@simm.ac.cn) ; Cheng, Zhen(zcheng@simm.ac.cn)
英文摘要Fibroblast activation protein (FAP) has recently gained significant attention as a promising tumor biomarker for both diagnosis and therapeutic applications. A series of radiopharmaceuticals based on fibroblast activation protein inhibitors (FAPIs) have been developed and translated into the clinic. Though some of them such as radiolabeled FAPI-04 probes have achieved favorable in vivo imaging performance, further improvement is still highly desired for obtaining radiopharmaceuticals with a high theranostics potential. In this study, we innovatively designed an FAPI ligand SMIC-3002 by changing the core quinoline motif of FAPI-04 to the quinolinium scaffold. The engineered molecule was further radiolabeled with Ga-68 to generate a positron emission tomography (PET) probe, [Ga-68]Ga-SMIC-3002, which was then evaluated in vitro and in vivo. [Ga-68]Ga-SMIC-3002 demonstrated high in vitro stability, nanomolar affinity for FAP (8 nM for protein, 23 nM for U87MG cells), and specific uptake in FAP-expressing tumors, with a tumor/muscle ratio of 19.1 and a tumor uptake of 1.48 +/- 0.03 ID/g% at 0.5 h in U87MG tumor-bearing mice. In summary, the quinolinium scaffold can be successfully used for the development of the FAP-targeted tracer. [Ga-68]Ga-SMIC-3002 not only shows high potential for clinical translation but also offers insights into designing a new generation of FAPI tracers.
资助项目National Natural Science Foundation of China[U2267221] ; National Natural Science Foundation of China[81901799] ; Shanghai Municipal Science and Technology Major Project[TM202301H003] ; Gansu Science and Technology Major Project[23ZDFA014] ; Shandong Laboratory Program[SYS202205]
WOS研究方向Biochemistry & Molecular Biology ; Chemistry
语种英语
WOS记录号WOS:001261362400001
出版者AMER CHEMICAL SOC
源URL[http://119.78.100.183/handle/2S10ELR8/312128]  
专题新药研究国家重点实验室
通讯作者Song, Shaoli; Zhu, Weiliang; Cheng, Zhen
作者单位1.Bohai Rim Adv Res Inst Drug Discovery, Shandong Lab Yantai Drug Discovery, Yantai 264117, Shandong, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China
3.Fudan Univ, Shanghai Canc Ctr, Dept Nucl Med, Shanghai 200032, Peoples R China
4.Northeastern Univ, Coll Life & Hlth Sci, Inst Mol Med, Shenyang 110167, Peoples R China
5.Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Sch Med, Dept Nucl Med, Shanghai 200235, Peoples R China
6.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
7.Chinese Acad Sci, Shanghai Inst Mat Med, Mol Imaging Ctr, Drug Discovery & Design Ctr,State Key Lab Drug Res, Shanghai 201203, Peoples R China
8.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 201203, Peoples R China
推荐引用方式
GB/T 7714
Li, Lei,Cao, Rui,Chen, Kaixin,et al. Development of an FAP-Targeted PET Probe Based on a Novel Quinolinium Molecular Scaffold[J]. BIOCONJUGATE CHEMISTRY,2024:9.
APA Li, Lei.,Cao, Rui.,Chen, Kaixin.,Qu, Chunrong.,Qian, Kun.,...&Cheng, Zhen.(2024).Development of an FAP-Targeted PET Probe Based on a Novel Quinolinium Molecular Scaffold.BIOCONJUGATE CHEMISTRY,9.
MLA Li, Lei,et al."Development of an FAP-Targeted PET Probe Based on a Novel Quinolinium Molecular Scaffold".BIOCONJUGATE CHEMISTRY (2024):9.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。